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INTRODUCTION

ABSTRACT
INTRODUCTION: Neurofibromatosis type 1 (NF1) is a genetic
disorder caused by a mutation in the NF1 gene. In addition to
physical manifestations, complications such as cognitive and
behavioral deficits have been described.
CLINICAL FINDINGS: We describe a case of a 14-year-old
male with a past psychiatric history of obsessive-compulsive
disorder (OCD), attention deficit hyperactivity disorder (ADHD),
and multiple suicide attempts, who presented with suicidal
ideation and command hallucinations. The patient became
aggressive, physically assaulting hospital staff, and required
sedative medication and physical restraints for several days. He
required inpatient hospital admission due to rhabdomyolysis.
Throughout his admission, the patient was intermittently verbally
and physically abusive to people around him. They described his
outbursts as impulsive and thought to be out of motivation to
get what he wants. He preferred to keep to himself and did not
have relationships with people at his home.
CONCLUSION: This case report provides insight into the
behavioral characterization of children diagnosed with NF1.
While the mechanism of how NF1 relates to behavioral issues
is unknown, the association between NF1 and behavioral issues
should be carefully considered in NF1 patients presenting with
aggression.
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eurofibromatosis type 1 (NF1)
is an autosomal dominant genetic disorder caused by a loss
of function mutation in the NF1 gene on
chromosome 17 that encodes the protein
neurofibromin.1 The function of neurofibromin is as a tumor suppressor protein
by stimulating RAS expression through
GTPase activity.2 NF1 is a multi-system
disease that has a variable phenotypic
presentation. Dermatologic manifestations of NF1 include multiple cafe-aulait spots, Lisch nodules, neurofibromas,
and skinfold freckling. Optic gliomas are
also common, leading to vision loss.1,3
The most common complications of NF1
are cognitive and behavioral deficits,
such as attention-deficit hyperactivity
disorder (ADHD) and autism spectrum
disorder (ASD).1 Children with NF1 have
been described as having autistic traits
and symptoms, highlighting a deficit in
social functioning.4 Furthermore, specific learning disorders in reading, writing,
and mathematics, as well as deficits in
cognitive domains, such as visual-spatial
performance and executive functioning,
have been noted in children with NF1.5
Our patient with a confirmed diagnosis of
NF1 initially presented to the Emergency Department (ED) with the complaint
of suicidal and homicidal ideation after a
conflict with a peer. During subsequent
hospital admission, he was intermittently
agitated and defiant, cursing and physically assaulting hospital staff. He has a
long psychiatric history and multiple prior psychiatric hospitalizations as well as
suicide attempts. The patient also has a
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strong family history of NF1, including a parent and
grandparent. He was diagnosed with NF with optic
gliomas that have been monitored with annual ophthalmologic visits.
Research on NF1 patients has produced evidence
that these patients have poor social functioning and
cognitive impairment.6 While the focus has been
placed on cognitive and physical manifestations of
NF1, in this article, we present a case of an adolescent with NF1 and severe behavioral abnormalities.
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Figure 1: Magnetic resonance imaging of
the brain. Diffuse thickening of the bilateral
pre-chiasmatic optic nerves extending into the
optic chiasm and continuing into the bilateral
optic tracts (red arrows), most likely related
to an optic nerve glioma given the history of
neurofibromatosis1.

CASE PRESENTATION

History of Present Illness

A 14-year-old male with a past psychiatric history
of obsessive-compulsive disorder (OCD), ADHD,
and multiple suicide attempts presented himself after running away from a care home due to a conflict with his peers. On presentation to the ED, he
reported suicidal and homicidal thoughts and was
subsequently transferred to the emergency room. He
reported that he sat in the street trying to get hit by
a car because his peers hit and bullied him. During
the psychiatric evaluation, he reported auditory
command hallucinations telling him to jump in front
of a car and lay on train tracks. He also endorsed a
history of self-injurious behaviors that involved intermittently scratching his body.
He had two prior ED evaluation after running away
from his care home and sitting in the street with the
plan of being hit by a car. He was ultimately discharged back to the care home after a mental health
evaluation. At the time, it was thought that the patient’s actions were motivated by him not liking his
living situation and having conflicts with his peers.
The patient’s past psychiatric history includes numerous inpatient psychiatric hospital visits in the
past few years. Specifically, a month prior to this
visit, he was brought to the ED for agitation and suicidal ideation. He was placed in an inpatient psychiatric hospital twice in the past months to address
his suicidal ideation and behavioral problem. He has
physically assaulted other people by hitting, biting,
and spitting when he does not get what he wants or
does not agree with what he is being asked to do.
During the most recent ED visit, the patient was
heard threatening to kill anyone he sees. He continued his outburst by throwing things and hitting people around him. His outbursts have been described
as impulsive and as reactions to not having his way.
Although he stated he has a good relationship with
his immediate family members, he prefers to keep
to himself and has not made relationships with peo© Tower Health
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ple around him. He is currently in school with good
grades but still requires special education.
EXAMINATION
On exam, the patient was well-groomed, cooperative, and well-dressed. His behavior was guarded,
withdrawn, and he avoided eye contact. His speech
was brief, with a normal rate and tone. He described
his mood as “okay”. His affect was constricted, and
his mood is congruent. His thought process was linear and goal directed. He reported command auditory
hallucinations telling him to sit in front of cars, active
suicidality with a plan to cut himself, and endorsed
homicidal ideation. He had poor insight and poor
judgment. He had been self-harming by scratching
his arm. He denied changes in sleep, appetite, energy
levels, focus, and concentration. On physical exam,
there was evidence of a neurofibroma (subcutaneous
forehead mass), axillary freckling bilaterally, and
cafe au lait spots on the trunk and back.
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INVESTIGATION

DISCUSSION

An MRI obtained during this admission revealed
thickening of the pre-chiasmatic optic nerves, chiasm,
and optic tracts likely related to the optic glioma, as
well as nonspecific T2 hyperintensities within the
right putamen and left centrum semi-ovale (Figure 1).
He required restraints for several days intermittently that prompted a check of creatine phosphokinase
(CPK) which was elevated at 1879 IU/L (reference
range 38-258 IU/L). He was subsequently admitted to
a medical-surgical floor for management of his rhabdomyolysis.
The patient was started on IV normal saline for
treatment of rhabdomyolysis with an initial CPK of
1879 IU/L, after which CPK returned to normal limits within five days. A urinalysis was also performed
and was negative for myoglobinuria. Basic metabolic workup was non-contributory.
TREATMENT
Throughout the hospital admission, the patient was
intermittently aggressive. He consistently voiced
his wishes to be placed into an inpatient psychiatric
facility and not discharged to his former residence.
While he was awaiting admission to placement in
mental health emergency department, he was intermittently agitated and defiant, cursing and physically assaulting people around him requiring administration of as needed (PRN) dosing of intramuscular
haloperidol 2mg and lorazepam 1mg.
All home medications (Chlorpromazine, Clonidine,
Dexmethylphenidate, and Divalproex sodium) were
restarted during his admission. Due to his symptoms, the chlorpromazine dose was increased from
150mg to 300 mg twice daily. In addition, intramuscular haloperidol 2mg PRN was discontinued, and
he was instead started on intramuscular olanzapine
5 mg PRN for agitation. After completion of his
treatment for rhabdomyolysis, he was discharged to
inpatient psychiatric care.
DIFFERENTIAL DIAGNOSIS
Other conditions were considered in the differential
diagnoses. The patient has a past psychiatric history
of obsessive-compulsive disorder (ODD), which is
supported by his continued loss of temper, disobedience to authority, emotions of anger and resentment,
and the deliberate annoyance of others; however,
OCD does not manifest as physical aggression. Bipolar disorder was ruled out due to the lack of manic
or hypomanic symptoms.
© Tower Health
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This case study demonstrates insight into the behavioral characterization of children diagnosed with
NF1. Most research available has been focused on
cognitive or physical manifestations of NF1, not the
emotional-psychological impact NF1 has on children. Evidence shows that there are extensive neurobehavioral disorders among NF1 patients, including
alterations in memory, language, cognitive skill, intelligence, and academic performance.1,7 Our patient
has a comorbid diagnosis of ADHD, and reported
good grades at school, but receives special education
as well. Combined, children with NF1 and ADHD
have been shown to have intermittent reactive and
aggressive behavior due to poor inhibitory control
rather than maladjustment of social functioning in
relation to reading facial expressions and voices.8 Using Social Skills Rating Systems, NF1 patients have
been shown to have poorer social skills than normal
children.7 This detriment regarding social skills leads
to a decrease in social outcomes. Children with a comorbid diagnosis of ADHD and NF1 have the poorest outcomes in regard to social functioning.9 In our
patient, he did not see his responses to violence as
an issue. There was little to no remorse about his actions when asked to reflect on his behavior. Research
has suggested brain abnormalities, such as reduced
white matter integrity, macrocephaly, and abnormal
gamma-aminobutyric acid (GABA)-activity, may be
responsible for the social and behavioral difficulties
in patients diagnosed with NF1.10 Behavioral difficulties reported include poor social skills, and both
internalizing and externalizing behavior problems.11
This is shown through our patient’s intermittent agitation before and during his hospital admission. It
has been noted that children with NF1 have difficulty
engaging in successful peer relationships; in addition,
these children are more likely to be victims of teasing because of weak interpersonal skills and ADHDlike behaviors rather than physical manifestations of
NF1.12 Interestingly, it has been shown that children
with NF1 have also been found to be targets of bullying behavior.13 It is unclear whether our patient was
a victim of bullying at school or in his peer home,
though he did admit to frequent disagreements with
his peers and a lack of positive social relationships.
Perhaps bullying behavior may be contributing to
the behavioral issues with patient with NF1. Future
research needs to be performed to determine the impact of neurobehavioral symptoms in patients with
NF1. Additionally, future research should seek to
determine the underlying mechanism explaining the
occurrence of agitated behavior in patients with NF1.
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CONCLUSIONS
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